Kristin Risa

806 total citations
10 papers, 351 citations indexed

About

Kristin Risa is a scholar working on Psychiatry and Mental health, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Kristin Risa has authored 10 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 4 papers in Neurology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Kristin Risa's work include Fibromyalgia and Chronic Fatigue Syndrome Research (9 papers), Peripheral Neuropathies and Disorders (3 papers) and Long-Term Effects of COVID-19 (3 papers). Kristin Risa is often cited by papers focused on Fibromyalgia and Chronic Fatigue Syndrome Research (9 papers), Peripheral Neuropathies and Disorders (3 papers) and Long-Term Effects of COVID-19 (3 papers). Kristin Risa collaborates with scholars based in Norway, Netherlands and Denmark. Kristin Risa's co-authors include Olav Mella, Øystein Fluge, Olav Dahl, Ove Bruland, Dipak Sapkota, Einar K. Kristoffersen, Halvor Næss, Anette Storstein, Harald Nyland and Kine Alme and has published in prestigious journals such as PLoS ONE, Marine Drugs and Clinical Therapeutics.

In The Last Decade

Kristin Risa

9 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristin Risa Norway 6 293 103 51 49 30 10 351
Ruud CW Vermeulen Netherlands 8 228 0.8× 57 0.6× 46 0.9× 36 0.7× 43 1.4× 11 308
Victoria Strassheim United Kingdom 9 171 0.6× 76 0.7× 47 0.9× 31 0.6× 33 1.1× 15 289
Ingrid G. Rekeland Norway 6 187 0.6× 84 0.8× 44 0.9× 19 0.4× 20 0.7× 10 207
Kari Sørland Norway 6 182 0.6× 84 0.8× 42 0.8× 19 0.4× 20 0.7× 10 205
Zariah Abdul Aziz Malaysia 11 54 0.2× 112 1.1× 44 0.9× 21 0.4× 75 2.5× 37 375
S. Wroe United Kingdom 6 259 0.9× 56 0.5× 119 2.3× 13 0.3× 4 0.1× 10 435
Valentina Floris Italy 8 93 0.3× 62 0.6× 10 0.2× 22 0.4× 7 0.2× 19 272
Yalin Guan China 10 112 0.4× 41 0.4× 5 0.1× 20 0.4× 18 0.6× 18 313
Joseph T. Hormes United States 8 51 0.2× 126 1.2× 96 1.9× 6 0.1× 38 1.3× 11 475
Danah Aljaafari Saudi Arabia 10 125 0.4× 64 0.6× 37 0.7× 3 0.1× 10 0.3× 51 277

Countries citing papers authored by Kristin Risa

Since Specialization
Citations

This map shows the geographic impact of Kristin Risa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristin Risa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristin Risa more than expected).

Fields of papers citing papers by Kristin Risa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristin Risa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristin Risa. The network helps show where Kristin Risa may publish in the future.

Co-authorship network of co-authors of Kristin Risa

This figure shows the co-authorship network connecting the top 25 collaborators of Kristin Risa. A scholar is included among the top collaborators of Kristin Risa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristin Risa. Kristin Risa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Fluge, Øystein, Ingrid G. Rekeland, Kari Sørland, et al.. (2025). Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study. Frontiers in Medicine. 12. 1607353–1607353.
2.
Rekeland, Ingrid G., Kari Sørland, Alexander Fosså, et al.. (2024). Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. PLoS ONE. 19(7). e0307484–e0307484. 3 indexed citations
3.
Rekeland, Ingrid G., Kari Sørland, Ove Bruland, et al.. (2022). Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients. PLoS ONE. 17(9). e0274472–e0274472. 5 indexed citations
4.
Hoel, Fredrik, Ina K. N. Pettersen, Ingrid G. Rekeland, et al.. (2021). A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. JCI Insight. 6(16). 34 indexed citations
5.
Rekeland, Ingrid G., Alexander Fosså, Kari Sørland, et al.. (2020). Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study. Frontiers in Medicine. 7. 162–162. 22 indexed citations
6.
Rekeland, Ingrid G., Øystein Fluge, Kine Alme, et al.. (2018). Rituximab Serum Concentrations and Anti-Rituximab Antibodies During B-Cell Depletion Therapy for Myalgic Encephalopathy/Chronic Fatigue Syndrome. Clinical Therapeutics. 41(5). 806–814. 3 indexed citations
7.
Kristoffersen, Einar K., Dipak Sapkota, Kristin Risa, et al.. (2016). Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome. PLoS ONE. 11(8). e0161226–e0161226. 20 indexed citations
8.
Fluge, Øystein, Kristin Risa, Kine Alme, et al.. (2015). B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment. PLoS ONE. 10(7). e0129898–e0129898. 89 indexed citations
9.
Opsahl, Jill A., et al.. (2013). Identification of Dynamic Changes in Proteins Associated with the Cellular Cytoskeleton after Exposure to Okadaic Acid. Marine Drugs. 11(6). 1763–1782. 27 indexed citations
10.
Fluge, Øystein, Ove Bruland, Kristin Risa, et al.. (2011). Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study. PLoS ONE. 6(10). e26358–e26358. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruud CW Vermeulen Breakdown of academic impact, for papers by Victoria Strassheim Breakdown of academic impact, for papers by Ingrid G. Rekeland Breakdown of academic impact, for papers by Kari Sørland Breakdown of academic impact, for papers by Zariah Abdul Aziz Breakdown of academic impact, for papers by S. Wroe Breakdown of academic impact, for papers by Valentina Floris Breakdown of academic impact, for papers by Yalin Guan Breakdown of academic impact, for papers by Joseph T. Hormes Breakdown of academic impact, for papers by Danah Aljaafari
Rankless by CCL
2026